{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T16:11:49Z","timestamp":1790611909112,"version":"4.1.0"},"reference-count":35,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,5,12]],"date-time":"2025-05-12T00:00:00Z","timestamp":1747008000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000024","name":"Canadian Institutes of Health Research","doi-asserted-by":"publisher","award":["PJT-148491"],"award-info":[{"award-number":["PJT-148491"]}],"id":[{"id":"10.13039\/501100000024","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000024","name":"Canadian Institutes of Health Research","doi-asserted-by":"publisher","award":["TCO-125269"],"award-info":[{"award-number":["TCO-125269"]}],"id":[{"id":"10.13039\/501100000024","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000024","name":"Canadian Institutes of Health Research","doi-asserted-by":"publisher","award":["HET-85515"],"award-info":[{"award-number":["HET-85515"]}],"id":[{"id":"10.13039\/501100000024","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000156","name":"Sant\u00e9","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000156","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002879","name":"Canadian Institutes of Health Research Canadian HIV Trials Network","doi-asserted-by":"publisher","award":["MOP-93770"],"award-info":[{"award-number":["MOP-93770"]}],"id":[{"id":"10.13039\/501100002879","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","journalofinfection.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Infection"],"published-print":{"date-parts":[[2025,7]]},"DOI":"10.1016\/j.jinf.2025.106511","type":"journal-article","created":{"date-parts":[[2025,5,19]],"date-time":"2025-05-19T19:34:12Z","timestamp":1747683252000},"page":"106511","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"title":["Evidence of greater immune aging among untreated HIV slow progressors than antiretroviral-controlled people living with HIV"],"prefix":"10.1016","volume":"91","author":[{"given":"Anthony Y.Y.","family":"Hsieh","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Renying","family":"Cai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5311-9409","authenticated-orcid":false,"given":"Nicole F.","family":"Bernard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C\u00e9cile L.","family":"Tremblay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0399-5141","authenticated-orcid":false,"given":"H\u00e9l\u00e8ne C.F.","family":"C\u00f4t\u00e9","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"7","key":"10.1016\/j.jinf.2025.106511_bib1","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1093\/gerona\/glt168","article-title":"Is HIV a model of accelerated or accentuated aging?","volume":"69","author":"Pathai","year":"2014","journal-title":"J Gerontol A Biol Sci Med Sci"},{"issue":"1","key":"10.1016\/j.jinf.2025.106511_bib2","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1097\/01.qai.0000233310.90484.16","article-title":"Mortality in the highly active antiretroviral therapy era: changing causes of death and disease in the HIV outpatient study","volume":"43","author":"Palella","year":"2006","journal-title":"J Acquir Immune Defic Syndr"},{"key":"10.1016\/j.jinf.2025.106511_bib3","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1146\/annurev-med-042909-093756","article-title":"HIV infection, inflammation, immunosenescence, and aging","volume":"62","author":"Deeks","year":"2011","journal-title":"Annu Rev Med"},{"issue":"5","key":"10.1016\/j.jinf.2025.106511_bib4","doi-asserted-by":"crossref","first-page":"2061","DOI":"10.1172\/JCI117892","article-title":"CD8 naive T cell counts decrease progressively in HIV-infected adults","volume":"95","author":"Roederer","year":"1995","journal-title":"J Clin Invest"},{"issue":"1","key":"10.1016\/j.jinf.2025.106511_bib5","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0016459","article-title":"The dual impact of HIV-1 infection and aging on na\u00efve CD4 T-cells: additive and distinct patterns of impairment","volume":"6","author":"Rickabaugh","year":"2011","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.jinf.2025.106511_bib6","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0085613","article-title":"Composition and function of T cell subpopulations are slow to change despite effective antiretroviral treatment of HIV disease","volume":"9","author":"Emu","year":"2014","journal-title":"PLoS One"},{"issue":"3","key":"10.1016\/j.jinf.2025.106511_bib7","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1097\/QAI.0b013e31825e7ac1","article-title":"T-Cell subset distribution in HIV-1\u2013infected patients after 12 years of treatment-induced viremic suppression","volume":"61","author":"R\u00f6nsholt","year":"2012","journal-title":"JAIDS J Acquir Immune Defic Syndr"},{"issue":"12","key":"10.1016\/j.jinf.2025.106511_bib8","doi-asserted-by":"crossref","first-page":"1924","DOI":"10.1086\/375372","article-title":"Age-related immune dysfunction in health and in human immunodeficiency virus (HIV) disease: association of age and HIV infection with naive CD8+ cell depletion, reduced expression of CD28 on CD8+ cells, and reduced thymic volumes","volume":"187","author":"Kalayjian","year":"2003","journal-title":"J Infect Dis"},{"issue":"2","key":"10.1016\/j.jinf.2025.106511_bib9","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1093\/infdis\/jiw146","article-title":"T-Cell activation independently associates with immune senescence in HIV-infected recipients of long-term antiretroviral treatment","volume":"214","author":"Cobos Jim\u00e9nez","year":"2016","journal-title":"J Infect Dis"},{"issue":"8","key":"10.1016\/j.jinf.2025.106511_bib10","doi-asserted-by":"crossref","first-page":"F17","DOI":"10.1097\/00002030-199607000-00001","article-title":"Shortened telomeres in the expanded CD28-CD8+ cell subset in HIV disease implicate replicative senescence in HIV pathogenesis","volume":"10","author":"Effros","year":"1996","journal-title":"AIDS"},{"issue":"11","key":"10.1016\/j.jinf.2025.106511_bib11","doi-asserted-by":"crossref","first-page":"5893","DOI":"10.4049\/jimmunol.168.11.5893","article-title":"Lack of antibody production following immunization in old age: association with CD8(+)CD28(-) T cell clonal expansions and an imbalance in the production of Th1 and Th2 cytokines","volume":"168","author":"Saurwein-Teissl","year":"2002","journal-title":"J Immunol"},{"issue":"15","key":"10.1016\/j.jinf.2025.106511_bib12","doi-asserted-by":"crossref","first-page":"2375","DOI":"10.1097\/QAD.0b013e328363bf7f","article-title":"Accelerated biological ageing in HIV-infected individuals in South Africa: a case-control study","volume":"27","author":"Pathai","year":"2013","journal-title":"AIDS"},{"issue":"9","key":"10.1016\/j.jinf.2025.106511_bib13","doi-asserted-by":"crossref","first-page":"1322","DOI":"10.1093\/cid\/ciu051","article-title":"Association between short leukocyte telomere length and HIV infection in a cohort study: No evidence of a relationship with antiretroviral therapy","volume":"58","author":"Zanet","year":"2014","journal-title":"Clin Infect Dis"},{"issue":"11","key":"10.1016\/j.jinf.2025.106511_bib14","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1056\/NEJMoa012035","article-title":"Changes in mitochondrial DNA as a marker of nucleoside toxicity in HIV-infected patients","volume":"346","author":"C\u00f4t\u00e9","year":"2002","journal-title":"N Engl J Med"},{"issue":"4","key":"10.1016\/j.jinf.2025.106511_bib15","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1002\/jmv.10423","article-title":"Depletion of mitochondrial DNA in HIV-1-infected patients and its amelioration by antiretroviral therapy","volume":"70","author":"Miura","year":"2003","journal-title":"J Med Virol"},{"issue":"4","key":"10.1016\/j.jinf.2025.106511_bib16","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0230772","article-title":"Correlation between blood telomere length and CD4+ CD8+ T-cell subsets changes 96 weeks after initiation of antiretroviral therapy in HIV-1\u2013positive individuals","volume":"15","author":"Chalouni","year":"2020","journal-title":"PLOS ONE"},{"issue":"10","key":"10.1016\/j.jinf.2025.106511_bib17","doi-asserted-by":"crossref","first-page":"1523","DOI":"10.1093\/infdis\/jiy399","article-title":"Blood telomere length changes after ritonavir-boosted darunavir combined with raltegravir or tenofovir-emtricitabine in antiretroviral-naive adults infected with HIV-1","volume":"218","author":"Stella-Ascariz","year":"2018","journal-title":"J Infect Dis"},{"issue":"3","key":"10.1016\/j.jinf.2025.106511_bib18","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1038\/s41591-019-0381-y","article-title":"A clinically meaningful metric of immune age derived from high-dimensional longitudinal monitoring","volume":"25","author":"Alpert","year":"2019","journal-title":"Nat Med"},{"issue":"2","key":"10.1016\/j.jinf.2025.106511_bib19","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1093\/ije\/21.2.387","article-title":"Asymptomatic subjects at HIV diagnosis have prolonged survival as AIDS patients","volume":"21","author":"Eskild","year":"1992","journal-title":"Int J Epidemiol"},{"key":"10.1016\/j.jinf.2025.106511_bib20","unstructured":"UNAIDS committee:\u00a0Joint United Nations Programme On HIV\/AIDS; 2020:1\u2013248."},{"key":"10.1016\/j.jinf.2025.106511_bib21","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2021.103258","article-title":"A high prevalence of potential HIV elite controllers identified over 30 years in Democratic Republic of Congo","volume":"65","author":"Berg","year":"2021","journal-title":"EBioMedicine"},{"issue":"11","key":"10.1016\/j.jinf.2025.106511_bib22","doi-asserted-by":"crossref","first-page":"e760","DOI":"10.1016\/S2352-3018(19)30234-6","article-title":"Adolescent HIV treatment in South Africa's national HIV programme: a retrospective cohort study","volume":"6","author":"Maskew","year":"2019","journal-title":"Lancet HIV"},{"issue":"12","key":"10.1016\/j.jinf.2025.106511_bib23","doi-asserted-by":"crossref","first-page":"e878","DOI":"10.1016\/S2352-3018(19)30264-4","article-title":"HIV controllers: to treat or not to treat? Is that the right question?","volume":"6","author":"No\u00ebl","year":"2019","journal-title":"Lancet HIV"},{"issue":"2","key":"10.1016\/j.jinf.2025.106511_bib24","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1007\/s40506-018-0158-8","article-title":"Current treatment options for HIV elite controllers: a review","volume":"10","author":"Promer","year":"2018","journal-title":"Curr Treat Options Infect Dis"},{"issue":"1","key":"10.1016\/j.jinf.2025.106511_bib25","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/S0753-3322(00)88637-0","article-title":"Analysis of telomere length and thymic output in fast and slow\/non-progressors with HIV infection","volume":"54","author":"Richardson","year":"2000","journal-title":"Biomed Pharm"},{"issue":"5","key":"10.1016\/j.jinf.2025.106511_bib26","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0063744","article-title":"Different immunological phenotypes associated with preserved CD4+ T cell counts in HIV-infected controllers and viremic long term non-progressors","volume":"8","author":"Gaardbo","year":"2013","journal-title":"PLoS One"},{"issue":"9","key":"10.1016\/j.jinf.2025.106511_bib27","doi-asserted-by":"crossref","first-page":"3679","DOI":"10.1182\/blood-2008-01-135442","article-title":"Telomerase activity of HIV-1-specific CD8+ T cells: constitutive up-regulation in controllers and selective increase by blockade of PD ligand 1 in progressors","volume":"112","author":"Lichterfeld","year":"2008","journal-title":"Blood"},{"issue":"2","key":"10.1016\/j.jinf.2025.106511_bib28","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1097\/QAI.0b013e3181926c28","article-title":"Premature aging of T cells is associated with faster HIV-1 disease progression","volume":"50","author":"Cao","year":"2009","journal-title":"J Acquir Immune Defic Syndr"},{"issue":"6","key":"10.1016\/j.jinf.2025.106511_bib29","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1042\/CS20140481","article-title":"Age-associated telomere attrition of lymphocytes in vivo is co-ordinated with changes in telomerase activity, composition of lymphocyte subsets and health conditions","volume":"128","author":"Lin","year":"2015","journal-title":"Clin Sci (Lond)"},{"issue":"11","key":"10.1016\/j.jinf.2025.106511_bib30","doi-asserted-by":"crossref","first-page":"1692","DOI":"10.1093\/infdis\/jiu809","article-title":"Hospitalization rates and reasons among HIV elite controllers and persons with medically controlled HIV infection","volume":"211","author":"Crowell","year":"2015","journal-title":"J Infect Dis"},{"issue":"1","key":"10.1016\/j.jinf.2025.106511_bib31","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-022-19970-3","article-title":"Elite controllers long-term non progressors present improved survival and slower disease progression","volume":"12","author":"Capa","year":"2022","journal-title":"Sci Rep"},{"key":"10.1016\/j.jinf.2025.106511_bib32","doi-asserted-by":"crossref","DOI":"10.1155\/2016\/5371050","article-title":"Systematic and cell type-specific telomere length changes in subsets of lymphocytes","volume":"2016","author":"Lin","year":"2016","journal-title":"J Immunol Res"},{"issue":"1","key":"10.1016\/j.jinf.2025.106511_bib33","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/S0047-6374(00)00210-4","article-title":"Age-related change in peripheral blood T-lymphocyte subpopulations and cytomegalovirus infection in the very old: the Swedish longitudinal OCTO immune study","volume":"121","author":"Olsson","year":"2001","journal-title":"Mech Ageing Dev"},{"issue":"10","key":"10.1016\/j.jinf.2025.106511_bib34","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0163770","article-title":"Adjusting MtDNA quantification in whole blood for peripheral blood platelet and leukocyte counts","volume":"11","author":"Hurtado-Roca","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.jinf.2025.106511_bib35","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/j.mito.2020.03.001","article-title":"Platelet mtDNA content and leukocyte count influence whole blood mtDNA content","volume":"52","author":"Shim","year":"2020","journal-title":"Mitochondrion"}],"container-title":["Journal of Infection"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0163445325001057?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0163445325001057?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,29]],"date-time":"2026-07-29T13:08:35Z","timestamp":1785330515000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0163445325001057"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7]]},"references-count":35,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025,7]]}},"alternative-id":["S0163445325001057"],"URL":"https:\/\/doi.org\/10.1016\/j.jinf.2025.106511","relation":{},"ISSN":["0163-4453"],"issn-type":[{"value":"0163-4453","type":"print"}],"subject":[],"published":{"date-parts":[[2025,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Evidence of greater immune aging among untreated HIV slow progressors than antiretroviral-controlled people living with HIV","name":"articletitle","label":"Article Title"},{"value":"Journal of Infection","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jinf.2025.106511","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Crown Copyright \u00a9 2025 Published by Elsevier Ltd on behalf of The British Infection Association.","name":"copyright","label":"Copyright"}],"article-number":"106511"}}